Phaseline

Targets › ZIP

ZIP (Zinc finger CCCH-type with G patch domain-containing protein): drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 2; Respiratory; next expected readout Jan 2027.

Transcription repressor that specifically binds the 5'-GGAG[GA]A[GA]A-3' consensus sequence. Represses transcription by recruiting the chromatin multiprotein complex NuRD to target promoters. (UniProt, Q8N5A5)

Open in Phaseline: the race on ZIP, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Cedars-Sinai Medical CenterZinc
Zinc supplementation; mechanism in IPF unclear but may involve antioxidant and anti-inflam
ZIPPhase 2Idiopathic Pulmonary FibrosisJan 2027

Conditions

Idiopathic Pulmonary Fibrosis (1)

Modalities

small molecule (1)

Companies

Cedars-Sinai Medical Center (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.